Cellectar Biosciences, Inc.
Price Action
Technical Summary
WEAKENINGCellectar Biosciences, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 19), showing significant lag compared to the market leaders. Earnings growth of 26% provides fundamental context to the price action. However, price is extended 21% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.85 | +23.83% | ABOVE |
| 50 SMA | $2.92 | +21.04% | ABOVE |
| 100 SMA | $3.08 | +14.57% | ABOVE |
| 150 SMA | $3.36 | +5.19% | ABOVE |
| 200 SMA | $3.76 | -6.11% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CLRB in an uptrend right now?
CLRB has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is CLRB overbought or oversold?
CLRB's RSI (14) is 64. The stock is in neutral territory, neither overbought nor oversold.
Is CLRB outperforming the market?
CLRB has a Relative Strength (RS) Rating of 19 out of 99. CLRB is currently lagging the broader market.
Where is CLRB in its 52-week range?
CLRB is trading at $3.53, which is 17% of its 52-week high ($20.59) and 6% above its 52-week low ($2.43).
How volatile is CLRB?
CLRB has a Beta of 1.76 and 52-week volatility of 116%. It's more volatile than the S&P 500 - expect bigger swings.